| Product Code: ETC5293506 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Suriname Nuclear Medicine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Starting at -0.34% in 2025, the market peaks at 1.90% in 2027, and settles at 1.69% by 2029.

By 2027, Suriname's Nuclear Medicine market is forecasted to achieve a stable growth rate of 1.90%, with Brazil leading the Latin America region, followed by Mexico, Argentina, Colombia and Chile.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Nuclear Medicine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Nuclear Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Nuclear Medicine Market - Industry Life Cycle |
3.4 Suriname Nuclear Medicine Market - Porter's Five Forces |
3.5 Suriname Nuclear Medicine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Nuclear Medicine Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Suriname Nuclear Medicine Market Revenues & Volume Share, By Volume Assessment, 2021 & 2031F |
4 Suriname Nuclear Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine diagnostics and treatments in Suriname |
4.2.2 Growing awareness and adoption of advanced medical technologies in the country |
4.2.3 Government initiatives to improve healthcare infrastructure and access to nuclear medicine services |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals specialized in nuclear medicine in Suriname |
4.3.2 High initial investment and operational costs associated with setting up nuclear medicine facilities in the country |
5 Suriname Nuclear Medicine Market Trends |
6 Suriname Nuclear Medicine Market Segmentations |
6.1 Suriname Nuclear Medicine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Nuclear Medicine Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.3 Suriname Nuclear Medicine Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.1.4 Suriname Nuclear Medicine Market Revenues & Volume, By Brachytherapy Isotopes, 2021-2031F |
6.2 Suriname Nuclear Medicine Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Suriname Nuclear Medicine Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.3 Suriname Nuclear Medicine Market, By Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Suriname Nuclear Medicine Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Suriname Nuclear Medicine Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
7 Suriname Nuclear Medicine Market Import-Export Trade Statistics |
7.1 Suriname Nuclear Medicine Market Export to Major Countries |
7.2 Suriname Nuclear Medicine Market Imports from Major Countries |
8 Suriname Nuclear Medicine Market Key Performance Indicators |
8.1 Patient volume growth rate for nuclear medicine procedures in Suriname |
8.2 Number of partnerships or collaborations with international healthcare organizations for knowledge sharing and technology transfer |
8.3 Percentage increase in government funding allocated to nuclear medicine infrastructure and services |
8.4 Average wait time for nuclear medicine procedures in Suriname |
8.5 Number of research studies or clinical trials conducted using nuclear medicine technologies in the country |
9 Suriname Nuclear Medicine Market - Opportunity Assessment |
9.1 Suriname Nuclear Medicine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Nuclear Medicine Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Suriname Nuclear Medicine Market Opportunity Assessment, By Volume Assessment, 2021 & 2031F |
10 Suriname Nuclear Medicine Market - Competitive Landscape |
10.1 Suriname Nuclear Medicine Market Revenue Share, By Companies, 2024 |
10.2 Suriname Nuclear Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here